Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3284273 | Clinical Gastroenterology and Hepatology | 2009 | 6 Pages |
Abstract
When international treatment guidelines are strictly followed, Crohn's disease patients can achieve high rates of remission and low rates of morbidity at 5 years. Indiscriminate use of biologic agents therefore is not appropriate for all patients with moderate-to-severe disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Garret Cullen, Denise Keegan, Hugh E. Mulcahy, Diarmuid P. O'Donoghue,